On Friday, Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) trading session started at the price of On Friday, that was 3.62% up from the session before settling in for the closing price of $3.59. A 52-week range for AMLX has been $1.58 – $19.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2300.59% over the past five years. When this article was written, the company’s average yearly earnings per share was at -718.93%. With a float of $48.47 million, this company’s outstanding shares have now reached $68.55 million.
Let’s look at the performance matrix of the company that is accounted for 384 employees. In terms of profitability, gross margin is 31.54%, operating margin of -126.88%, and the pretax margin is -131.04%.
Amylyx Pharmaceuticals Inc (AMLX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Amylyx Pharmaceuticals Inc stocks. The insider ownership of Amylyx Pharmaceuticals Inc is 29.45%, while institutional ownership is 70.43%. The most recent insider transaction that took place on Feb 03 ’25, was worth 12,839. In this transaction Chief Legal Officer of this company sold 3,678 shares at a rate of $3.49, taking the stock ownership to the 139,090 shares. Before that another transaction happened on Feb 03 ’25, when Company’s Co-Chief Executive Officer sold 11,851 for $3.47, making the entire transaction worth $41,108. This insider now owns 3,201,247 shares in total.
Amylyx Pharmaceuticals Inc (AMLX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -718.93% per share during the next fiscal year.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators
You can see what Amylyx Pharmaceuticals Inc (AMLX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.55. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.82, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) saw its 5-day average volume 0.57 million, a negative change from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 47.47%. Additionally, its Average True Range was 0.27.
During the past 100 days, Amylyx Pharmaceuticals Inc’s (AMLX) raw stochastic average was set at 19.32%, which indicates a significant decrease from 67.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.08% in the past 14 days, which was lower than the 81.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.90, while its 200-day Moving Average is $3.14. Nevertheless, the first resistance level for the watch stands at $3.79 in the near term. At $3.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.99. If the price goes on to break the first support level at $3.59, it is likely to go to the next support level at $3.47. The third support level lies at $3.39 if the price breaches the second support level.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Key Stats
There are 68,548K outstanding shares of the company, which has a market capitalization of 255.01 million. As of now, sales total 380,790 K while income totals 49,270 K. Its latest quarter income was 420 K while its last quarter net income were -72,700 K.
